National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019

United States116th CongressHR-220House of Representatives
Updated: Jan 25, 2019

Summary

National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019 This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group. The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must: support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders; establish a surveillance system to track the prevalence of such diseases and disorders in humans; establish a surveillance system to track the prevalence of disease-carrying ticks; conduct educational campaigns; and hold a series of research symposiums.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.